肺がん手術の世界市場2019-2029

LINEで送る

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Key Product USP Analysis

4.2. Regulatory Scenario

4.3. Reimbursement Scenario

4.4. Value Chain

4.5. Disease Epidemiology by Region

5. Global Lung Cancer Surgery Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Global GDP Growth Outlook

6.1.2. Global Healthcare Market Outlook

6.2. Forecast Factors – Relevance & Impact

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Global Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029

7.3.1. Thoracoscopes

7.3.2. Mediastinoscopes

7.3.3. Bronchoscopes

7.3.4. Robotic-Assisted Thoracic Surgery Systems

7.3.5. Surgical Staplers

7.3.6. Surgical Energy Instruments

7.3.6.1. Advanced Energy Instruments

7.3.6.1.1. Advanced Bipolar Instruments

7.3.6.1.2. Ultrasonic Instruments

7.3.6.2. Basic Energy Instruments

7.3.6.2.1. Bipolar Instruments

7.3.6.2.2. Monopolar Instruments

7.4. Market Attractiveness Analysis By Product Type

8. Global Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, by Application

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Application, 2014 – 2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019 – 2029

8.3.1. Lobectomy

8.3.2. Segmentectomy

8.3.3. Wedge Resection

8.3.4. Pneumonectomy

8.4. Market Attractiveness Analysis By Application

9. Global Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, by End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029

9.3.1. Hospitals

9.3.2. Ambulatory Surgical Centers

9.4. Market Attractiveness Analysis By End User

10. Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029, By Region

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018

10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. Middle East and Africa (MEA)

10.3.5. East Asia

10.3.6. South Asia

10.3.7. Oceania

10.4. Market Attractiveness Analysis By Region

11. North America Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Product Type

11.3.3. By Application

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Product Type

11.4.3. By Application

11.4.4. By End User

12. Latin America Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Mexico

12.3.1.3. Rest of Latin America

12.3.2. By Product Type

12.3.3. By Application

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product Type

12.4.3. By Application

12.4.4. By End User

13. Europe Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

13.3. Market Size (US$ Mn) and By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. U.K.

13.3.1.5. Spain

13.3.1.6. Russia

13.3.1.7. Rest of Europe

13.3.2. By Product Type

13.3.3. By Application

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Application

13.4.4. By End User

14. South Asia Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Country

14.3.1.1. India

14.3.1.2. Thailand

14.3.1.3. Indonesia

14.3.1.4. Malaysia

14.3.1.5. Rest of South Asia

14.3.2. By Product Type

14.3.3. By Application

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Application

14.4.4. By End User

15. East Asia Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Product Type

15.3.3. By Application

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Application

15.4.4. By End User

16. Oceania Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Product Type

16.3.3. By Application

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Application

16.4.4. By End User

17. Middle East and Africa Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 – 2018

17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. Turkey

17.3.1.3. Northern Africa

17.3.1.4. South Africa

17.3.1.5. Rest of Middle East and Africa

17.3.2. By Product Type

17.3.3. By Application

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Type

17.4.3. By Application

17.4.4. By End User

18. Emerging Countries Lung Cancer Surgery Market Analysis 2014-2018 and Forecast 2019-2029

18.1. Introduction

18.1.1. Market Value Proportion Analysis, By Key Countries

18.1.2. Global Vs. Country Growth Comparison

18.2. China Lung Cancer Surgery Market Analysis

18.2.1. Introduction

18.2.2. Market Value Proportion Analysis by Market Taxonomy

18.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

18.2.3.1. By Product Type

18.2.3.2. By Application

18.2.3.3. By End User

18.2.4. China Lung Cancer Surgery Market – Competition Landscape

18.3. India Lung Cancer Surgery Market Analysis

18.3.1. Introduction

18.3.2. Market Value Proportion Analysis by Market Taxonomy

18.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

18.3.3.1. By Product Type

18.3.3.2. By Application

18.3.3.3. By End User

18.3.4. India Lung Cancer Surgery Market – Competition Landscape

18.4. Brazil Lung Cancer Surgery Market Analysis

18.4.1. Introduction

18.4.2. Market Value Proportion Analysis by Market Taxonomy

18.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

18.4.3.1. By Product Type

18.4.3.2. By Application

18.4.3.3. By End User

18.4.4. Brazil Lung Cancer Surgery Market – Competition Landscape

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Concentration

19.3. Market Share Analysis of Top Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Deep Dive

20.2.1. Asap Endoscopic Products

20.2.1.1. Overview

20.2.1.2. Product Portfolio

20.2.1.3. Profitability by Market Segments (Product/Channel/Region)

20.2.1.4. Sales Footprint

20.2.1.5. Strategy Overview

20.2.2. Ethicon Inc. (J & J)

20.2.2.1. Overview

20.2.2.2. Product Portfolio

20.2.2.3. Profitability by Market Segments (Product/Channel/Region)

20.2.2.4. Sales Footprint

20.2.2.5. Strategy Overview

20.2.3. Medtronic Plc.

20.2.3.1. Overview

20.2.3.2. Product Portfolio

20.2.3.3. Profitability by Market Segments (Product/Channel/Region)

20.2.3.4. Sales Footprint

20.2.3.5. Strategy Overview

20.2.4. Germed USA Inc.

20.2.4.1. Overview

20.2.4.2. Product Portfolio

20.2.4.3. Profitability by Market Segments (Product/Channel/Region)

20.2.4.4. Sales Footprint

20.2.4.5. Strategy Overview

20.2.5. Teleflex Incorporated

20.2.5.1. Overview

20.2.5.2. Product Portfolio

20.2.5.3. Profitability by Market Segments (Product/Channel/Region)

20.2.5.4. Sales Footprint

20.2.5.5. Strategy Overview

20.2.6. B. Braun Melsungen AG

20.2.6.1. Overview

20.2.6.2. Product Portfolio

20.2.6.3. Profitability by Market Segments (Product/Channel/Region)

20.2.6.4. Sales Footprint

20.2.6.5. Strategy Overview

20.2.7. Karl Storz

20.2.7.1. Overview

20.2.7.2. Product Portfolio

20.2.7.3. Profitability by Market Segments (Product/Channel/Region)

20.2.7.4. Sales Footprint

20.2.7.5. Strategy Overview

20.2.8. Richard Wolf

20.2.8.1. Overview

20.2.8.2. Product Portfolio

20.2.8.3. Profitability by Market Segments (Product/Channel/Region)

20.2.8.4. Sales Footprint

20.2.8.5. Strategy Overview

20.2.9. Olympus Medical Systems Corp

20.2.9.1. Overview

20.2.9.2. Product Portfolio

20.2.9.3. Profitability by Market Segments (Product/Channel/Region)

20.2.9.4. Sales Footprint

20.2.9.5. Strategy Overview

20.2.10. Intuitive Surgical Inc.

20.2.10.1. Overview

20.2.10.2. Product Portfolio

20.2.10.3. Profitability by Market Segments (Product/Channel/Region)

20.2.10.4. Sales Footprint

20.2.10.5. Strategy Overview

20.2.11. Ambu A/S

20.2.11.1. Overview

20.2.11.2. Product Portfolio

20.2.11.3. Profitability by Market Segments (Product/Channel/Region)

20.2.11.4. Sales Footprint

20.2.11.5. Strategy Overview

20.2.12. PENTAX Medical Company

20.2.12.1. Overview

20.2.12.2. Product Portfolio

20.2.12.3. Profitability by Market Segments (Product/Channel/Region)

20.2.12.4. Sales Footprint

20.2.12.5. Strategy Overview

20.2.13. FUJIFILM Holdings Corporation

20.2.13.1. Overview

20.2.13.2. Product Portfolio

20.2.13.3. Profitability by Market Segments (Product/Channel/Region)

20.2.13.4. Sales Footprint

20.2.13.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様